Petrolatum
CAS 8009-03-8
Petrolatum (CAS 8009-03-8) is a pharmaceutical compound with 0 bioactivity targets and 905 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Cross-Reference to Chemicals
Same-CAS substance identity is available in the industrial chemicals vertical.
Petrolatum is linked to DTXSID6027686 in DSSTox identifiers.
View industrial chemical data →Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| Petrolatum | 8091 | SU | MTHSPL |
| PETROLATUM | 8091 | SU | MTHSPL |
| petrolatum | 8091 | SU | MTHSPL |
| petrolatum | 8091 | IN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Petrolatum used for in pharmaceutical contexts?
Petrolatum (CAS 8009-03-8) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Petrolatum?
Petrolatum has 905 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Abdominal pain, Abdominal pain upper, Abdominal rigidity, Acute kidney injury, Acute respiratory failure. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Petrolatum also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Vaseline (Petrolatum) with EU status "permitted".
What clinical phase is Petrolatum in?
No phase 1-4 clinical development badge is rendered for Petrolatum because the matched compound identifier rows do not contain a max-phase value.